Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 10.43B | 11.06B | 9.47B | 8.96B | 8.09B |
Gross Profit | 3.78B | 4.00B | 3.21B | 3.02B | 2.64B |
EBITDA | 1.61B | 1.75B | 1.56B | 1.53B | 1.14B |
Net Income | 1.02B | 1.08B | 847.46M | 830.93M | 545.37M |
Balance Sheet | |||||
Total Assets | 13.79B | 13.01B | 10.06B | 9.96B | 8.93B |
Cash, Cash Equivalents and Short-Term Investments | 2.95B | 2.43B | 1.45B | 1.64B | 1.24B |
Total Debt | 5.40B | 4.63B | 3.66B | 3.72B | 4.15B |
Total Liabilities | 9.59B | 8.40B | 6.26B | 6.51B | 6.21B |
Stockholders Equity | 4.20B | 4.61B | 3.80B | 3.45B | 2.72B |
Cash Flow | |||||
Free Cash Flow | 0.00 | 1.40B | 410.38M | 924.12M | 844.03M |
Operating Cash Flow | 0.00 | 1.68B | 576.37M | 1.03B | 1.02B |
Investing Cash Flow | 0.00 | -1.15B | 223.08M | -104.40M | -260.95M |
Financing Cash Flow | 0.00 | 505.02M | -987.67M | -530.06M | -528.63M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥19.43B | 13.92 | 1.72% | 22.80% | 39.62% | ||
75 Outperform | ¥15.26B | 15.81 | 2.11% | 25.64% | ― | ||
73 Outperform | ¥13.29B | 22.91 | 3.05% | 6.14% | 4.14% | ||
71 Outperform | ¥13.16B | 10.42 | 3.56% | -6.96% | -1.72% | ||
66 Neutral | $2.75B | 14.13 | 10.02% | 4.01% | -1.82% | 30.90% | |
57 Neutral | ¥12.46B | 16.16 | 1.99% | 25.48% | ― | ||
54 Neutral | ¥12.86B | ― | 5.58% | -6.30% | 34.61% |